Conavi Medical Announces Limited Market Release of the Novasight Vantage Hybrid Imaging System
Conavi Medical Inc., (“Conavi” or the “Company”) developer of the Novasight Hybrid System and a leader of hybrid imaging guidance for minimally invasive cardiovascular interventions, today announced the limited market release for their new Novasight Vantage hybrid imaging system in... Read More →
Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study
Novel Adaptive Superiority Trial Design of ProtEmbo® Cerebral Embolic Protection (CEP) System AACHEN, Germany–(BUSINESS WIRE)–Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the FDA has approved the PROTEMBO Pivotal IDE Trial (NCT05873816). The trial will recruit... Read More →
2023 Houston Innovation Awards finalists announced featuring CellChorus
In just three weeks, all of Houston’s innovation ecosystem will gather to celebrate the hard work of startups, entrepreneurs, investors, mentors, and more — and over 50 honorees will be recognized for their achievements. Read More
Sidekick Health acquires PDTx company and more digital health announcements
Digital care management platform Sidekick Health announced it acquired Hamburg-based aidhere, a prescription digital therapeutic for people with obesity. Sidekick develops personalized digital therapeutics and programs for chronic and lifestyle disease management, ranging from diabetes to ulcerative colitis and smoking... Read More →
Senzo Health Raises Additional $1.8M in Funding
Senzo Health, a London, UK-based life sciences company developing diagnostic technologies, raised additional $1.8M in funding. The backers were not disclosed. Read More
ZKR Orthopedics announces FDA Breakthrough Device designation for the LIFT Implant Technology
KENTFIELD, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) — ZKR Orthopedics, Inc., a clinical stage medical device company, today announced that its LIFT implant technology has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). The LIFT... Read More →
AI brain imaging device receives FDA clearance
South Korean startup Vuno’s AI-powered brain imaging device has received the 510(k) certification from the U.S. Food and Drug Administration (FDA), signaling the company’s expansion into U.S. markets where it hopes to improve the early diagnosis of dementia. The Vuno... Read More →
Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial
The PROACTIVE-HF 2 trial is designed to expand access to NYHA class II patients and to scale pulmonary artery pressure-guided therapy with the Cordella Sensor In addition, the Company presented positive 12-month clinical data on a subset of patients in... Read More →
Rhaeos, Inc. Receives $1.5 Million Blueprint MedTech Grant from the NIH to Transform Hydrocephalus Management
EVANSTON, Ill., Oct. 9, 2023 /PRNewswire/ — Rhaeos, Inc, a clinical stage medical device technology company, is pleased to announce that it has been awarded a $1.5 million grant (Federal Award # 1UG3NS130338) from the National Institutes of Health (NIH)... Read More →
RevBio Awarded a $3.4 Million NIH Grant for Its Novel Regenerative Bone Adhesive to Treat Complex Fractures
This Grant will Fund the Company’s Translational Research Activities Through the Completion of a Pilot Clinical Trial. LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has been awarded a grant from the National Institute on Aging (NIA), part of the National... Read More →